Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Revenue	$ 4,957,489	$ 4,485,062	$ 9,575,030	$ 8,720,406
Cost of goods sold	4,472,911	3,767,851	8,965,396	7,732,093
Gross Profit	484,578	717,211	609,634	988,313
Operating Expenses:
Selling expenses	812,568	855,122	1,530,584	1,372,701
General and administrative expenses	1,539,323	1,541,316	2,901,569	3,086,047
Research and development expenses	242,556	407,292	472,679	662,104
Total Operating Expenses	2,594,447	2,803,730	4,904,832	5,120,852
Loss from Operations	(2,109,869)	(2,086,519)	(4,295,198)	(4,132,539)
Other Income (Expense):
Interest and other income	64,605	45,744	133,356	114,830
Interest expense	(63,466)	(29,290)	(111,749)	(101,009)
Amortization of debt discount	(84,318)	(150,591)	(252,348)	(296,631)
Gain (loss) on foreign currency transactions	34,060	84,462	69,576	339,998
Gain (loss) on disposal of property and equipment	(2,158)	10,344	(63,464)	(453,233)
Total Other Expense	(51,277)	(39,331)	(224,629)	(396,045)
Loss Before Income Taxes	(2,161,146)	(2,125,850)	(4,519,827)	(4,528,584)
Income tax benefit	(360)	(14,150)	(699)	(28,589)
Net Loss	(2,160,786)	(2,111,700)	(4,519,128)	(4,499,995)
Net Loss attributable to noncontrolling interest	(8,901)	0	(15,851)	0
Net Loss attributable to LiqTech International, Inc.	$ (2,151,885)	$ (2,111,700)	$ (4,503,277)	$ (4,499,995)
Loss Per Common Share – Basic and Diluted (in dollars per share)	$ (0.22)	$ (0.36)	$ (0.47)	$ (0.77)
Weighted-Average Common Shares Outstanding – Basic and Diluted (in shares)	9,606,902	5,808,127	9,606,902	5,806,480